title: Intravenous immunoglobulin in secondary progressive multiple sclerosis: randomised placebo-controlled trial.
authors.affiliation: European Charcot Foundation, Nijmegen, Netherlands. info@charcot-ms.org
authors.forename: Otto R
authors.initials: OR
authors.lastname: Hommes
authors.forename: Per S
authors.initials: PS
authors.lastname: Sørensen
authors.forename: Franz
authors.initials: F
authors.lastname: Fazekas
authors.forename: Monika Maas
authors.initials: MM
authors.lastname: Enriquez
authors.forename: Hans W
authors.initials: HW
authors.lastname: Koelmel
authors.forename: Oscar
authors.initials: O
authors.lastname: Fernandez
authors.forename: Carlo
authors.initials: C
authors.lastname: Pozzilli
authors.forename: Paul
authors.initials: P
authors.lastname: O'Connor
mesh_terms: D000328:Adult; D001921:Brain / Q000473:pathology; D018450:Disease Progression; D004311:Double-Blind Method; D005260:Female; D006801:Humans; D016756:Immunoglobulins, Intravenous / Q000627:therapeutic use*; D008279:Magnetic Resonance Imaging; D008297:Male; D020528:Multiple Sclerosis, Chronic Progressive / Q000175:diagnosis / Q000473:pathology / Q000628:therapy*
chemical_list: D016756:Immunoglobulins, Intravenous